+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5263846
The global blood glucose monitoring devices market size is expected to reach USD 23.21 billion by 2030. The market is expected to expand at a CAGR of 8.25% from 2024 to 2030. Patients with diabetes and their healthcare professionals benefit significantly from Blood Glucose Monitoring Devices (BGMD). BGMD is becoming more widely accepted as an important component of intensive diabetic treatment. It allows diabetic patients to measure their blood sugar levels within minutes with ease and convenience wherever they are. The continuous glucose monitoring (CGM) devices help analyze the blood glucose level continuously and in real-time. It also helps patients determine the level of dietary intake and dosage of insulin. In addition, factors such as sedentary lifestyles including consumption of junk food, alcohol, and smoking, and a surge in the need for safer and faster diagnoses are expected to boost the market growth during the forecast period.

According to the International Diabetes Federation (IDF), the total number of diabetic patients is expected to expand to 643 million (11.3 %) by 2030 and 783 million (12.2 %) by 2045. Obesity is one of the major factors propelling the prevalence of diabetes. Obese individuals are up to 80 times more likely than non-obese persons to develop diabetes. Studies suggest that 650 million people over the age of 18 are obese. Further, due to the ongoing efforts by the government and healthcare organizations such as the International Diabetes Federation (IDF) to control diabetes, the market is likely to rise at a rapid pace throughout the forecast period. Through a network of stakeholders and collaborators, these organizations provide needed expertise and support diabetes awareness campaigns. Rising health-care funding is also expected to boost market growth.

Blood Glucose Monitoring Devices Market Report Highlights

  • North America held the largest revenue share in 2023 owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
  • Based on product, the self-monitoring devices segment held the largest revenue share of 66.37% in 2023 and is expected to grow at a significant pace over the forecast period
  • The continuous blood glucose monitoring devices product segment is expected to be the fastest-growing segment during the forecast period
  • In the self-monitoring devices, the testing strips segment accounted for the largest revenue share in 2023 owing to the high usage of these strips and affordability.
  • By end-use, the home care segment is expected to grow at a rapid pace during the forecast period

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
Chapter 2. Blood Glucose Monitoring Devices Market: Executive Summary
2.1. Market Snapshot
2.2. Products and End Use Snapshots
2.3. Competitive Landscape Snapshot
Chapter 3. Blood Glucose Monitoring Devices Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising geriatric population worldwide
3.4.2. Increasing number of diabetes patients
3.4.3. Increasing awareness about diabetes preventive care
3.5. Market Restraint Analysis
3.5.1. High cost of devices
3.6. Blood Glucose Monitoring Devices Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat Of New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political Landscape
3.6.2.2. Technological Landscape
3.6.2.3. Economic Landscape
3.6.3. Pricing Analysis
Chapter 4. Blood Glucose Monitoring Devices: Product Estimates & Trend Analysis
4.1. Global Blood Glucose Monitoring Market: Product Segment Dashboard
4.2. Global Blood Glucose Monitoring Devices Market by Product Outlook
4.3. Global Blood Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Self-Monitoring Devices
4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2. Blood Glucose Meter
4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.3. Testing Strips
4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.4. Lancets
4.4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.5. Continuous Blood Glucose Monitoring Devices
4.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.5.2. Sensors
4.5.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.5.3. Transmitter & Receiver
4.5.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.5.4. Insulin Pumps
4.5.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 5. Blood Glucose Monitoring Devices: End-use Estimates & Trend Analysis
5.1. Global Blood Glucose Monitoring Market: End-use Segment Dashboard
5.2. Global Blood Glucose Monitoring Market: End-use Movement Analysis
5.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.5. Homecare
5.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6. Diagnostics Centers
5.6.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Market Dashboard
6.2. Global Regional Market Snapshot
6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
6.4. North America
6.4.1. U.S.
6.4.1.1. Key Country Dynamics
6.4.1.2. Competitive Scenario
6.4.1.3. Regulatory Framework
6.4.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.3. Spain
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.6.5.
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6.2. China
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6.3. India
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6.5. Thailand
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Blood Glucose Monitoring Devices Market, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company /Competition Categorization
7.3. Vendor Landscape
7.3.1. List Of Key Distributors and Channel Partners
7.3.2. Key Customers
7.3.3. Key Company Market Share Analysis, 2023
7.3.4. Abbott
7.3.4.1. Overview
7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.4.3. Product Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Medtronic plc
7.3.5.1. Overview
7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.5.3. Product Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. F. Hoffmann-La Roche Ltd
7.3.6.1. Overview
7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.6.3. Product Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Ascensia Diabetes Care Holdings AG
7.3.7.1. Overview
7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.7.3. Product Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. LifeScan IP Holdings, LLC
7.3.8.1. Overview
7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.8.3. Product Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Dexcom, Inc
7.3.9.1. Overview
7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.9.3. Product Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. SANOFI
7.3.10.1. Overview
7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.10.3. Product Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Lilly (Elly Lilly and Company)
7.3.11.1. Overview
7.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.11.3. Product Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. B Braun SE
7.3.12.1. Overview
7.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.12.3. Product Benchmarking
7.3.12.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
Table 3 North America Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 4 North America Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 5 U.S. Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 6 U.S. Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 7 Canada Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 8 Canada Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 9 Europe Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
Table 10 Europe Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 11 Europe Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 12 UK Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 13 UK Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 14 Germany Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 15 Germany Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 16 France Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 17 France Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 18 Italy Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 19 Italy Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 20 Spain Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 21 Spain Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 22 Sweden Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 23 Sweden Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 24 Norway Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 25 Norway Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 26 Denmark Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 27 Denmark Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 31 Japan Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 32 Japan Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 33 China Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 34 China Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 35 India Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 36 India Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 37 Australia Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 38 Australia Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 39 South Korea Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 40 South Korea Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 41 Thailand Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 42 Thailand Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 43 Latin America Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
Table 44 Latin America Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 45 Latin America Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 46 Brazil Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 47 Brazil Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 48 Mexico Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 49 Mexico Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 50 Argentina Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 51 Argentina Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 52 MEA Blood Glucose Monitoring Devices Market, Region, 2018 - 2030 (USD Million)
Table 53 MEA Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 54 MEA Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 55 South Africa Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 56 South Africa Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 59 UAE Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 60 UAE Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
Table 61 Kuwait Blood Glucose Monitoring Devices Market, By Product, 2018 - 2030 (USD Million)
Table 62 Kuwait Blood Glucose Monitoring Devices Market, By End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews in North America
Fig. 5 Primary Interviews in Europe
Fig. 6 Primary Interviews In APAC
Fig. 7 Primary Interviews in Latin America
Fig. 8 Primary Interviews In MEA
Fig. 9 Market Research Approaches
Fig. 10 Value-Chain-Based Sizing & Forecasting
Fig. 11 QFD Modeling for Market Share Assessment
Fig. 12 Market Formulation & Validation
Fig. 13 Blood Glucose Monitoring Devices Market: Market Outlook
Fig. 14 Blood Glucose Monitoring Devices Competitive Insights
Fig. 15 Parent Market Outlook
Fig. 16 Related/Ancillary Market Outlook
Fig. 17 Penetration and Growth Prospect Mapping
Fig. 18 Industry Value Chain Analysis
Fig. 19 Blood Glucose Monitoring Devices Market Driver Impact
Fig. 20 Blood Glucose Monitoring Devices Market Restraint Impact
Fig. 21 Blood Glucose Monitoring Devices Market Strategic Initiatives Analysis
Fig. 22 Blood Glucose Monitoring Devices Market: Product Movement Analysis
Fig. 23 Blood Glucose Monitoring Devices Market: Product Outlook and Key Takeaways
Fig. 24 Self-Monitoring Devices Market Estimates and Forecast, 2018 - 2030
Fig. 25 Blood Glucose Meter Market Estimates and Forecast, 2018 - 2030
Fig. 26 Strips Market Estimates and Forecast, 2018 - 2030
Fig. 27 Lancets Market Estimates and Forecast, 2018 - 2030
Fig. 28 Continuous monitoring devices Market Estimates and Forecast, 2018 - 2030
Fig. 29 Sensor Market Estimates and Forecast, 2018 - 2030
Fig. 30 Transmitter and Receiver Market Estimates and Forecast, 2018 - 2030
Fig. 31 Insulin pumps Market Estimates and Forecast, 2018 - 2030
Fig. 32 Blood Glucose Monitoring Devices Market: End Use Movement Analysis
Fig. 33 Blood Glucose Monitoring Devices Market: End Use Outlook and Key Takeaways
Fig. 34 Hospitals Market Estimates and Forecasts, 2018 - 2030
Fig. 35 Home Care Market Estimates and Forecasts, 2018 - 2030
Fig. 36 Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030
Fig. 37 Global Blood Glucose Monitoring Devices Market: Regional Movement Analysis
Fig. 38 Global Blood Glucose Monitoring Devices Market: Regional Outlook and Key Takeaways
Fig. 39 North America Market Estimates and Forecasts, 2018 - 2030
Fig. 40 U.S. Market Estimates and Forecasts, 2018 - 2030
Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
Fig. 42 Europe Market Estimates and Forecasts, 2018 - 2030
Fig. 43 UK Market Estimates and Forecasts, 2018 - 2030
Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
Fig. 45 France Market Estimates and Forecasts, 2018 - 2030
Fig. 46 Italy Market Estimates and Forecasts, 2018 - 2030
Fig. 47 Spain Market Estimates and Forecasts, 2018 - 2030
Fig. 48 Denmark Market Estimates and Forecasts, 2018 - 2030
Fig. 49 Sweden Market Estimates and Forecasts, 2018 - 2030
Fig. 50 Norway Market Estimates and Forecasts, 2018 - 2030
Fig. 51 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
Fig. 52 China Market Estimates and Forecasts, 2018 - 2030
Fig. 53 Japan Market Estimates and Forecasts, 2018 - 2030
Fig. 54 India Market Estimates and Forecasts, 2018 - 2030
Fig. 55 Thailand Market Estimates and Forecasts, 2018 - 2030
Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
Fig. 58 Latin America Market Estimates and Forecasts, 2018 - 2030
Fig. 59 Brazil Market Estimates and Forecasts, 2018 - 2030
Fig. 60 Mexico Market Estimates and Forecasts, 2018 - 2030
Fig. 61 Argentina Market Estimates and Forecasts, 2018 - 2030
Fig. 62 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 63 South Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 64 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
Fig. 65 UAE Market Estimates and Forecasts, 2018 - 2030
Fig. 66 Kuwait Market Estimates and Forecasts, 2018 - 2030
Fig. 67 Market Categorization
Fig. 68 Market Share of Key Market Players- Blood Glucose Monitoring Devices Market

Companies Mentioned

  • Abbott
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Ascensia Diabetes Care Holdings AG
  • LifeScan IP Holdings, LLC
  • Dexcom, Inc
  • SANOFI
  • Lilly (Elly Lilly and Company)
  • B Braun SE

Methodology

Loading
LOADING...

Table Information